This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

9 Jul 2013

Potential myelodysplasia treatment pathway identified

A drug which targets an abnormal enzyme could prove effective in slowing myelodysplasia progression.

Scientists have identified a potential treatment pathway for myelodysplasia, a blood disorder for which there are currently few therapy options.


Related News